At Baylor Scott & White Health, the cohesive transplant services teams of physicians, surgeons and medical staff offer the expertise and compassion your patients deserve.
Blood stell cell transplants are among the most effective treatments for certain hematologic and lymphatic cancers.
We offer corneal transplantation performed by board-certified, fellowship-trained surgeons.
Our median wait time from listing to transplant for status 1A heart transplant patients is just seven days at Baylor University Medical Center, part of Baylor Scott & White Health.
We are the first health system in Texas the FDA permitted to process pancreatic islet cells for transplantation.
Our three-year patient survival outcomes for kidney transplants exceed the national average reported by the Scientific Registry of Transplant Recipients.
Our program is internationally recognized for pioneering the field of liver transplantation, anti-rejection treatments and hepatitis B and C research.
We have been performing lung transplants for patients with chronic lung disease for more than 25 years.
In September 2016, Baylor Dallas performed the first four living-donor uterine transplants in the United States.
Use our online tool to refer your patient to a transplant specialist at Baylor Scott & White Health.
Browse all Transplant locations
Clinical trials at Baylor Scott & White Health are an essential component in patient-centered care, health care effectiveness and quality of care research bringing innovative treatments from the laboratory workbench to your patient’s bedside.
Established in 1984, Baylor Scott & White Research Institute (BSWRI) is a dedicated research center for finding prevention therapies and treatments for diseases and illnesses.
The abdominal transplant fellowship training program at Baylor University Medical Center at Dallas was established in 1985 and is accredited by the American Society of Transplant Surgeons to train two fellows annually in liver, kidney and pancreas transplantation.